News
MYO
5.09
+6.04%
0.29
Weekly Report: what happened at MYO last week (1111-1115)?
Weekly Report · 6d ago
Myomo Price Target Maintained With a $7.50/Share by HC Wainwright & Co.
Dow Jones · 11/13 19:05
HC Wainwright & Co. Reiterates Buy on Myomo, Maintains $7.5 Price Target
Benzinga · 11/13 18:54
Myomo’s Strong Financial Performance and Strategic Expansion Drive Buy Rating
TipRanks · 11/13 11:29
Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 11/12 19:27
Myomo Is Maintained at Buy by Ascendiant Capital
Dow Jones · 11/12 10:02
Myomo Price Target Raised to $9.00/Share From $8.50 by Ascendiant Capital
Dow Jones · 11/12 10:02
Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $9
Benzinga · 11/12 09:52
Weekly Report: what happened at MYO last week (1104-1108)?
Weekly Report · 11/11 11:23
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/07 16:31
Analysts Offer Insights on Healthcare Companies: Petmed Express (PETS), Myomo (MYO) and Accuray (ARAY)
TipRanks · 11/07 14:00
Myomo, Inc. Reports Record Third Quarter Growth
TipRanks · 11/07 04:41
Myomo expects Q4 Sales Guidance of $9.50M-10.50M VS Est.9.8M
Benzinga · 11/06 22:16
Here are the major earnings after the close today
Seeking Alpha · 11/06 15:00
CMS Decision And O&P Network Build Out Make Myomo A Buy
Seeking Alpha · 11/05 20:30
Weekly Report: what happened at MYO last week (1028-1101)?
Weekly Report · 11/04 11:20
Analysts’ Top Healthcare Picks: Cigna (CI), Lemaitre Vascular (LMAT)
TipRanks · 11/01 13:00
Myomo Announces It Has Entered Into The First Contracts That Will Allow MyoPro To Be Provided To Patients Covered By Private Insurance On An In-Network Basis
Benzinga · 10/31 20:40
Myomo announces first private payer contracts for MyoPro In-network Coverage
TipRanks · 10/31 20:10
Weekly Report: what happened at MYO last week (1021-1025)?
Weekly Report · 10/28 11:13
More
Webull provides a variety of real-time MYO stock news. You can receive the latest news about Myomo through multiple platforms. This information may help you make smarter investment decisions.
About MYO
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.